Cite

HARVARD Citation

    Honap, S. et al. (2022). Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study. Frontline gastroenterology. 13 (6), pp. 517-523. [Online]. 
  
Back to record